L. Tipton, Fungi stabilize connectivity in the lung and skin microbial ecosystems, vol.6, p.12, 2018.

S. O'brien and J. L. Fothergill, The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung, FEMS Microbiol. Lett, vol.364, 2017.

S. T. Rush, C. H. Lee, W. Mio, and P. T. Kim, The Phylogenetic LASSO and the Microbiome. ArXiv160708877 Q-Bio Stat, 2016.

R. A. Quinn, Ecological networking of cystic fibrosis lung infections, NPJ Biofilms Microbiomes, vol.2, p.4, 2016.

Z. D. Kurtz, Sparse and compositionally robust inference of microbial ecological networks, Plos Comput. Biol, vol.11, p.1004226, 2015.

D. Berry and S. Widder, Deciphering microbial interactions and detecting keystone species with co-occurrence networks, Front. Microbiol, vol.5, p.219, 2014.

K. L. Whiteson, The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography, Am. J. Respir. Crit. Care Med, vol.189, pp.1309-1315, 2014.

J. M. Bhatt, Treatment of pulmonary exacerbations in cystic fibrosis, Eur. Respir. Rev. Off. J. Eur. Respir. Soc, vol.22, pp.205-216, 2013.

A. E. Stenbit and P. A. Flume, Pulmonary exacerbations in cystic fibrosis, Curr. Opin. Pulm. Med, vol.17, pp.442-447, 2011.

D. Bilton, Report from the EuroCareCF Working Group on outcome parameters in clinical trials, J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc, vol.10, issue.2, pp.79-81, 2011.

C. H. Goss and J. L. Burns, Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis, Thorax, vol.62, pp.360-367, 2007.

L. D. Nguyen, Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation, Plos One, vol.11, p.168860, 2016.

R. A. Quinn, Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease, PeerJ, vol.4, p.2174, 2016.

R. A. Quinn, A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation, ISME J, vol.9, pp.1024-1038, 2015.

L. A. Carmody, Changes in cystic fibrosis airway microbiota at pulmonary exacerbation, Ann. Am. Thorac. Soc, vol.10, pp.179-187, 2013.

M. M. Tunney, Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation, Am. J. Respir. Crit. Care Med, vol.187, pp.1118-1126, 2013.

E. T. Zemanick, Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations, Plos One, vol.8, p.62917, 2013.

L. M. Filkins, Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability, J. Bacteriol, vol.194, pp.4709-4717, 2012.

A. A. Fodor, The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations, Plos One, vol.7, p.45001, 2012.

J. Zhao, Decade-long bacterial community dynamics in cystic fibrosis airways, Proc. Natl. Acad. Sci. USA, vol.109, pp.5809-5814, 2012.

A. Goffard, Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients, J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol, vol.60, pp.147-153, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02266763

D. Willner, Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung, Am. J. Respir. Cell Mol. Biol, vol.46, pp.127-131, 2012.

F. Lysholm, Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing, Plos One, vol.7, p.30875, 2012.

S. H. Chotirmall, Sputum Candida albicans presages FEV 1 decline and hospital-treated exacerbations in cystic fibrosis, Chest, vol.138, pp.1186-1195, 2010.

R. Amin, A. Dupuis, S. D. Aaron, and F. Ratjen, The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis, Chest, vol.137, pp.171-176, 2010.

S. D. Willger, Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis, vol.2, p.40, 2014.

L. Delhaes, Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study 'MFIP', J. Cyst. Fibros, vol.18, pp.212-220, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02316590

J. Armstead, J. Morris, and D. W. Denning, Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis, Plos One, vol.9, p.98502, 2014.

P. G. Middleton, S. Chen, and W. Meyer, Fungal infections and treatment in cystic fibrosis, Curr. Opin. Pulm. Med, vol.19, pp.670-675, 2013.

J. J. Speirs, C. K. Van-der-ent, and J. M. Beekman, Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis, Curr. Opin. Pulm. Med, vol.18, pp.632-638, 2012.

D. Conrad, Cystic fibrosis therapy: a community ecology perspective, Am. J. Respir. Cell Mol. Biol, vol.48, pp.150-156, 2013.

Y. W. Lim, Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis, J. Clin. Microbiol, vol.52, pp.425-437, 2014.

D. A. Stevens, Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art, Cystic Fibrosis Foundation Consensus Conference, vol.37, pp.225-264, 2003.

P. E. Galand, E. O. Casamayor, D. L. Kirchman, and C. Lovejoy, Ecology of the rare microbial biosphere of the Arctic Ocean, Proc. Natl. Acad. Sci. USA, vol.106, pp.22427-22432, 2009.

H. Sokol, Fungal microbiota dysbiosis in IBD, Gut, vol.66, pp.1039-1048, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01270909

R. Kramer, Cohort Study of Airway Mycobiome in Adult Cystic Fibrosis Patients: Differences in Community Structure between Fungi and Bacteria Reveal Predominance of Transient Fungal Elements, J. Clin. Microbiol, vol.53, pp.2900-2907, 2015.

L. Delhaes, The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management, Plos One, vol.7, p.36313, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00806782

D. B. Sanders, Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation, Am. J. Respir. Crit. Care Med, vol.182, pp.627-632, 2010.

A. A. Heirali, The effects of inhaled aztreonam on the cystic fibrosis lung microbiome, vol.5, p.51, 2017.

G. Bacci, Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline, PloS One, vol.11, p.156807, 2016.

D. A. Hogan, Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease, Plos One, vol.11, p.149998, 2016.

L. Cuthbertson, Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention, ISME J, vol.10, pp.1081-1091, 2016.

L. D. Bos, S. Meinardi, D. Blake, and K. Whiteson, Bacteria in the airways of patients with cystic fibrosis are genetically capable of producing VOCs in breath, J. Breath Res, vol.10, p.47103, 2016.

F. Botterel, Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory, Mycopathologia, vol.183, pp.171-183, 2018.

M. Richardson, P. Bowyer, and R. Sabino, The human lung and Aspergillus: You are what you breathe in?, Med. Mycol, vol.57, pp.145-154, 2019.

R. Feigelman, Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details, Microbiome, vol.5, p.20, 2017.

S. H. Kim, Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation, Plos Pathog, vol.11, p.1005308, 2015.

S. Boutin and A. H. Dalpke, Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients, Mol. Cell. Pediatr, vol.4, p.1, 2017.

R. P. Dickson, Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography, Ann. Am. Thorac. Soc, vol.12, pp.821-830, 2015.

A. Venkataraman, Application of a neutral community model to assess structuring of the human lung microbiome, 2015.

C. Lamoureux, C. Guilloux, C. Beauruelle, A. Jolivet-gougeon, and G. Héry-arnaud, Anaerobes in cystic fibrosis patients' airways, Crit. Rev. Microbiol. 1-15, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02020470

L. J. Caverly and J. J. Lipuma, Good cop, bad cop: anaerobes in cystic fibrosis airways, Eur. Respir. J, vol.52, 2018.

G. B. Rogers, L. R. Hoffman, M. P. Carroll, and K. D. Bruce, Interpreting infective microbiota: the importance of an ecological perspective, Trends Microbiol, vol.21, pp.271-276, 2013.

M. N. Hurley and A. R. Smyth, Staphylococcus aureus in cystic fibrosis: pivotal role or bit part actor?, Curr. Opin. Pulm. Med, vol.24, pp.586-591, 2018.

A. Hector, Microbial colonization and lung function in adolescents with cystic fibrosis, J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc, vol.15, pp.340-349, 2016.

E. T. Zemanick, Airway microbiota across age and disease spectrum in cystic fibrosis, Eur. Respir. J, p.50, 2017.

H. C. Van-woerden, Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study, BMC Infect. Dis, vol.13, p.69, 2013.

J. Guillot, S. Hadina, and E. Guého, The genus Malassezia: old facts and new concepts, Parassitologia, vol.50, pp.77-79, 2008.

E. Kerem, Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry, Eur. Respir. J, vol.43, pp.125-133, 2014.

L. Pages-monteiro, Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa, Plos One, vol.12, p.173022, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01606726

F. J. Whelan, Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis, Plos One, vol.12, p.172811, 2017.

R. Somayaji, Long-term clinical outcomes of 'Prairie Epidemic Strain' Pseudomonas aeruginosa infection in adults with cystic fibrosis, Thorax, vol.72, pp.333-339, 2017.

G. K. Russell, R. Gadhok, and N. J. Simmonds, The destructive combination of Scediosporium apiosperum lung disease and exuberant inflammation in cystic fibrosis, Paediatr. Respir. Rev, vol.14, issue.1, pp.22-25, 2013.

C. Staerck, The secreted polyketide boydone A is responsible for the anti-Staphylococcus aureus activity of Scedosporium boydii, FEMS Microbiol. Lett, vol.364, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02407052

P. Vandeputte, Draft Genome Sequence of the Pathogenic Fungus Scedosporium apiospermum, Genome Announc, vol.2, p.3589, 2014.

Z. Han, L. Kautto, and H. Nevalainen, Secretion of Proteases by an Opportunistic Fungal Pathogen Scedosporium aurantiacum, Plos One, vol.12, p.169403, 2017.

W. Krüger, S. Vielreicher, M. Kapitan, I. D. Jacobsen, and M. J. Niemiec, Fungal-Bacterial Interactions in Health and Disease, Pathog. Basel Switz, vol.8, 2019.

K. F. Budden, Functional effects of the microbiota in chronic respiratory disease, Lancet Respir. Med, issue.18, pp.30510-30511, 2019.

L. Chiu, Protective Microbiota: From Localized to Long-Reaching Co-Immunity, Front. Immunol, vol.8, p.1678, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01673350

N. Coron, Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study, Mycopathologia, vol.183, pp.101-117, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01618715

J. Abbott, What defines a pulmonary exacerbation? The perceptions of adults with cystic fibrosis, J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc, vol.8, pp.356-359, 2009.

J. N. Paulson, O. C. Stine, H. C. Bravo, and M. Pop, Differential abundance analysis for microbial marker-gene surveys, Nat. Methods, vol.10, pp.1200-1202, 2013.

D. Gevers, The treatment-naive microbiome in new-onset Crohn's disease, Cell Host Microbe, vol.15, pp.382-392, 2014.

R. Enaud, Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances, J. Clin. Med, vol.8, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02126914

S. M. Prevaes, Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis, Am. J. Respir. Crit. Care Med, vol.193, pp.504-515, 2016.

C. Bernarde, Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation, Plos One, vol.10, p.124124, 2015.

Y. Maeda, Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF), J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc, vol.10, pp.133-139, 2011.

R. Tibshirani, The lasso method for variable selection in the Cox model, Stat. Med, vol.16, pp.385-395, 1997.

S. T. Rush, The Phylogenetic LASSO and the Microbiome: Metagenomic Modeling in Fecal Microbiota Transplantation, 2017.

F. R. Bach, Bolasso: model consistent Lasso estimation through the bootstrap, Proceedings of the 25th international conference on Machine learning -ICML'08, pp.33-40, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00271289